Tissue cross-reactivity studies of CPGJ701 in humans, cynomolgus monkeys and Sprague-Dawley rats and correlation analysis with in vivo toxicity

BACKGROUND: CPGJ701 is a recombinant humanized anti-human epidermal growth factor receptor-2 (HER2) monoclonal antibody-derivative of the cytotoxic agent maytansine (DM1) conjugate for the treatment of HER2-positive metastatic breast cancer. Tissue cross-reactivity (TCR) studies of CPGJ701 in a comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Zhe, Lyu, Jianjun, Liu, Yue, Wang, Xin, Lin, Zhi, Yang, Yanwei, Zhang, Di, Geng, Xingchao, Li, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186683/
https://www.ncbi.nlm.nih.gov/pubmed/32355769
http://dx.doi.org/10.21037/atm.2020.02.106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186683/
https://www.ncbi.nlm.nih.gov/pubmed/32355769
http://dx.doi.org/10.21037/atm.2020.02.106

Ejemplares similares